Skip to Main Content

Paper Details

Altered fibrinolysis in autosomal dominant thrombomodulin-associated coagulopathy.
Blood
13
2016
Plasma, TAFI, THBD, TM, TM model plasma, TM-AC, Thrombin in, Thrombomodulin, Thrombomodulin-associated coagulopathy, autosomal dominant thrombomodulin-associated coagulopathy, blood samples, dominant bleeding disorder, fibrinolytic, high-, plasma, protein C, prothrombin complex, recombinant activated factor VII, thrombin, thrombin-activatable fibrinolysis inhibitor, thrombomodulin, thrombomodulin (TM) gene, tissue factor
Author NameAffiliation
Sarah K WestburySchool of Clinical Sciences, University of Bristol
Kathleen StirrupsUniversity of Cambridge
Kathleen StirrupsUniversity of Cambridge
Kathleen StirrupsNational Institute for Health Research BioResource - Rare Diseases, Cambridge University Hospitals
Kathleen StirrupsNational Institute for Health Research BioResource - Rare Diseases, Cambridge University Hospitals
Ernest TurroUniversity of Cambridge
Ernest TurroMedical Research Council Biostatistics Unit, Cambridge Institute of Public Health
Ernest TurroNational Institute for Health Research BioResource - Rare Diseases, Cambridge University Hospitals
Ernest TurroUniversity of Cambridge
Ernest TurroNational Institute for Health Research BioResource - Rare Diseases, Cambridge University Hospitals
Ernest TurroMedical Research Council Biostatistics Unit, Cambridge Institute of Public Health
Andrew D MumfordSchool of Clinical Sciences, University of Bristol
Andrew D MumfordSchool of Clinical Sciences, University of Bristol
  • 1 - 13

Datasets

Release 1.2